Adverse reactions of different treatments in chronic hepatitis C
Hepatitis C virus infection is estimated to affect over 170 million people worldwide. Standard treatment for chronic HCV involves an interferon-based preparation and ribavirin for 24 to 48 weeks. These therapeutic regimens are associated with numerous adverse events, among which constitutional and neuropsychiatric symptoms, as well as hematological abnormalities, stand out. Adverse events resulting from the treatment of hepatitis C can jeopardize the quality of life of patients and their response to treatment. The control of those events involves medicinal and non-medicinal interventions. The latter include a reduction in the dosage of IFN or RBV and discontinuation of the treatment.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2009 |
|---|---|
| Erschienen: |
2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:113 |
|---|---|
| Enthalten in: |
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi - 113(2009), 4 vom: 08. Okt., Seite 991-5 |
| Sprache: |
Rumänisch |
|---|
| Weiterer Titel: |
Consideraţii privind reacţiile adverse ale terapiei specifice in hepatita cronică cu virus C |
|---|
| Beteiligte Personen: |
Luca, Cătălina [VerfasserIn] |
|---|
| Themen: |
3WJQ0SDW1A |
|---|
| Anmerkungen: |
Date Completed 14.05.2010 Date Revised 01.12.2018 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM19543708X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM19543708X | ||
| 003 | DE-627 | ||
| 005 | 20231223202748.0 | ||
| 007 | tu | ||
| 008 | 231223s2009 xx ||||| 00| ||rum c | ||
| 028 | 5 | 2 | |a pubmed24n0651.xml |
| 035 | |a (DE-627)NLM19543708X | ||
| 035 | |a (NLM)20191864 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rum | ||
| 100 | 1 | |a Luca, Cătălina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adverse reactions of different treatments in chronic hepatitis C |
| 246 | 3 | 3 | |a Consideraţii privind reacţiile adverse ale terapiei specifice in hepatita cronică cu virus C |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2010 | ||
| 500 | |a Date Revised 01.12.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Hepatitis C virus infection is estimated to affect over 170 million people worldwide. Standard treatment for chronic HCV involves an interferon-based preparation and ribavirin for 24 to 48 weeks. These therapeutic regimens are associated with numerous adverse events, among which constitutional and neuropsychiatric symptoms, as well as hematological abnormalities, stand out. Adverse events resulting from the treatment of hepatitis C can jeopardize the quality of life of patients and their response to treatment. The control of those events involves medicinal and non-medicinal interventions. The latter include a reduction in the dosage of IFN or RBV and discontinuation of the treatment | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Interferon alpha-2 |2 NLM | |
| 650 | 7 | |a Interferon-alpha |2 NLM | |
| 650 | 7 | |a Recombinant Proteins |2 NLM | |
| 650 | 7 | |a Polyethylene Glycols |2 NLM | |
| 650 | 7 | |a 3WJQ0SDW1A |2 NLM | |
| 650 | 7 | |a Ribavirin |2 NLM | |
| 650 | 7 | |a 49717AWG6K |2 NLM | |
| 650 | 7 | |a peginterferon alfa-2a |2 NLM | |
| 650 | 7 | |a Q46947FE7K |2 NLM | |
| 700 | 1 | |a Grigore, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Vâţă, A |e verfasserin |4 aut | |
| 700 | 1 | |a Dorobăţ, Carmen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi |d 1961 |g 113(2009), 4 vom: 08. Okt., Seite 991-5 |w (DE-627)NLM000103667 |x 0048-7848 |7 nnns |
| 773 | 1 | 8 | |g volume:113 |g year:2009 |g number:4 |g day:08 |g month:10 |g pages:991-5 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 113 |j 2009 |e 4 |b 08 |c 10 |h 991-5 | ||